Abiopharma

XPO Appoints Jonas Svedlund as Chief Legal Officer

Intel Announces Proposed $15 Billion Common Stock Offering

K Wave Media Appoints New Chairman and Co-CEO to Accelerate AI and Semiconductor Acquisition Strategy

Unaudited condensed interim consolidated financial statements as of June 30, 2026

Reports Second Quarter 2026 Financial Results

Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026

Silence Therapeutics - Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SPRY

Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

3D Systems Receives $9 Million Contract Award from U.S. Air Force for Advanced Large-Format Metal 3D Printing System